Article

Mycronic AB reported a 19% decline in order intake compared to the same quarter last year, while total net sales for 2025 increased by 12%. The operating margin fell to 17% in Q4 2025 from 26% the previous year, although strong performance in Global Technologies helped mitigate losses.

The company is investing in new technologies, notably a photomask inspection product to boost organic growth. It received orders for various equipment from its Pattern Generators division. The European PCB Assembly Solutions market remained weak, while the U.S. was stable and Asia showed growth. Mycronic's acquisition of German firm ETZ, which had nearly 4 million euros in sales in 2025, will integrate into its PCB Test area.